REVIEW PAPER
Economic burden of smoking-attributable diseases in China: A systematic review
Lili Shi 1, 2
,  
Lumin Zhong 3, 2
,  
Yuyang Cai 2, 4  
 
 
More details
Hide details
1
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2
School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China
3
Department of Epidemiology and Public Health, University College London, London, United Kingdom
4
NHC Key Laboratory of Health Economics and Policy Research, Shandong University, Jinan, China
CORRESPONDING AUTHOR
Yuyang Cai   

School of Public Health, Shanghai Jiao Tong University School of Medicine, 227 South Chongqing Road, 200025 Shanghai, China
Publication date: 2020-05-12
 
Tob. Induc. Dis. 2020;18(May):42
KEYWORDS
TOPICS
ABSTRACT
Introduction:
This review aims to synthesise the studies on smoking-attributable burden of diseases in China to assess the economic burden of smoking and highlight the weakness in these studies to inform future studies.

Methods:
A systematic search of studies on smoking-attributable burden of disease in seven databases was conducted in 2019 and studies were screened according to inclusion and exclusion criteria. The evaluation of studies was based on the seven key elements for burden of disease studies. Costs were converted into 2013 Renminbi (RMB), with 1000 RMB about 163 US$ in 2013, the year of the first search, using the Consumer Price Index and the then exchange rate.

Results:
Twenty studies were identified that estimated the costs of smoking in China, ranging from 57.162 to 368.273 billion RMB in total. The largest proportion of direct costs was allocated to outpatient visits, accounting for 49.17–68.94% of the direct costs. Meanwhile, costs resulting from mortality constituted 64.52–98.82% of the indirect costs. In mainland China, the understanding of PAR% (ratio of population attributable risk and incidence in the total population) in studies is not consistent. Studies on the cost of passive smoking are lacking and the research method for diseases needs to be improved.

Conclusions:
Smoking-attributable diseases have exerted substantial direct and indirect economic burden on China. The methodologies for future studies should be improved. Hong Kong and Taiwan provide good examples for future research in mainland China and researchers there should use PAR% correctly. More studies on the burden of passive smoking should be conducted. We propose a combination of single and all-disease research methods, if data are sufficient.

ACKNOWLEDGEMENTS
We thank the team members for their support and contributions to this study.
CONFLICTS OF INTEREST
The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.
FUNDING
This work was supported by the National Social Science Foundation of China (Grant No. 17BSH056), and the open project of NHC Key Laboratory of Health Economics and Policy Research (NHCHEPR2018005).
PROVENANCE AND PEER REVIEW
Not commissioned; externally peer reviewed.
 
REFERENCES (33)
1.
Zhang J, Qian X, Chen YY. [Research Progress on Burden of Disease]. Chinese Health Economics. 2005;24(5):69-71.
 
2.
Yang GH, Ma JM, Liu N, Zhou LN. [Smoking and passive smoking in Chinese, 2002]. Zhonghua Liu Xing Bing Xue Za Zhi [Chinese Journal of Epidemiology]. 2005;26(2):77-83. PMID: 15921604.
 
3.
Hu SL. [Study of Burden of Disease I]. Health Economics Research. 2005;(5):22-27.
 
4.
Tarricone R. Cost-of-illness analysis: What room in health economics? Health Policy. 2006;77(1):51-63. doi:10.1016/j.healthpol.2005.07.016.
 
5.
Zhu TY, Tam LS, Li EK. Cost-of-illness studies in systemic lupus erythematosus: A systematic review. Arthritis Care Res (Hoboken). 2011;63(5):751-760. doi:10.1002/acr.20410.
 
6.
Huang AJ, Zhan SY. [Systematic review and meta analysis]. Chinese Journal of Drug Application and Monitoring. 2009;6(4):257-259.
 
7.
Kang HY, Kim HJ, Park TK, Lee S, Nam C, Park H. Economic burden of smoking in Korea. Tob Control. 2003;12(1):37-44. doi:10.1136/tc.12.1.37.
 
8.
Miller VP, Ernst C, Collin F. Smoking-attributable medical care costs in the USA. Soc Sci Med. 1999;48(3):375-391. doi:10.1016/s0277-9536(98)00344-x.
 
9.
Jin SG, Lu BY, Yan DY, Fu ZY, Jiang Y, Li W. An evaluation on smoking-induced health costs in China (1988-1989). Biomed Environ Sci. 1995;8(4):342-349. PMID: 8719176.
 
10.
Jiang Y, Jin SG. [Attributable socioeconomic burden of smoking in China in 1998]. Chinese Health Economics. 2000;19(10):55-57.
 
11.
Sung HY, Wang L, Jin S, Hu TW, Jiang Y. Economic burden of smoking in China, 2000. Tob Control. 2006;15(Suppl 1):i5-i11. doi:10.1136/tc.2005.015412.
 
12.
Li L, Chen QL, Jia RX, Cui X. [The Smoking Pattern and Disease Burden of Tobacco Use in China]. Chinese Health Economics. 2008;27(1):26-30.
 
13.
Yang L, Sung HY, Mao Z, Hu TW, Rao K. Economic costs attributable to smoking in China: update and an 8-year comparison, 2000-2008. Tob Control. 2011;20(4):266-272. doi:10.1136/tc.2010.042028.
 
14.
Li SJ, Cai L, Shu ZS, et al. [Analysis of association of economic burden of hypertension with tobacco exposure in Luoping county of Yunnan province]. Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]. 2013;47(10):958-962. PMID: 24378140.
 
15.
Cai L, Cui W, He J, Wu X. The economic burden of smoking and secondhand smoke exposure in rural South-West China. J Asthma. 2014;51(5):515-521. doi:10.3109/02770903.2014.892964.
 
16.
Yao T, Sung HY, Mao Z, Hu T, Max W. The Healthcare Costs of Secondhand Smoke Exposure in Rural China. Tob Control. 2015;24:e221-e226. doi:10.1136/tobaccocontrol-2014-051621.
 
17.
Yang L, Huang YX, Sun Q, Wu M, Mao Z, Hu D. Study on Estimating the Indirect Economic Burden of Tobacco-Attribution: Based on Full Income Approach. Chinese Health Economics. 2015;34(12):79-81.
 
18.
Tang J. [Research on disease burden of lung cancer, stomach cancer, breast cancer attributable to smoking in Hangzhou, 2013]. Hangzhou Normal University; 2016.
 
19.
Chen JF, Ma HY, Tang J, Li JT, Ma XF. [An analysis on the disease burden of smoking in Hangzhou City]. Zhejiang Journal of Preventive Medicine. 2016;28(3):226-229.
 
20.
Yang LX, Li JT, Tang J, Chen JF, Ma H. [An analysis on non-medical cost contributed by smoking of smoking related diseases in main urban districts of Hangzhou]. Zhejiang Journal of Preventive Medicine. 2017;29(7):689-693.
 
21.
Qi Fei, Xu Zhenshi, Jia Xiaorong, et al. [Burden of disease attributable to cigarette smoking in Qingdao in 2015]. China Disease Control Magazine. 2018;22(4):354-357, 385.
 
22.
Ma XF, Wang JX, Ma HY. [Burden of disease attributable to smoking among rural residents in Hangzhou]. Chinese Rural Health Service Administration. 2018;(7):873-877.
 
23.
Wang Q, Li Y, Fan Z, et al. [Study on the relationship between passive smoking and disease burden of stroke in people aged 60 years and over in Jiangsu province, 2013]. Zhonghua Liu Xing Bing Xue Za Zhi [Chinese Journal of Epidemiology]. 2019;40(9):1089-1094. doi:10.3760/cma.j.issn.0254-6450.2019.09.013.
 
24.
Fan Z, Luo P, Su J, et al. [Analysis on the burden of cardio-cerebral vascular disease deaths attributed to smoking in inhabitants aged 30 years and above in Jiangsu Province]. Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]. 2019;53(3):267-271. doi:10.3760/cma.j.issn.0253-9624.2019.03.006.
 
25.
Leung GM, Ho LM, Lam TH. The economic burden of environmental tobacco smoke in the first year of life. Arch Dis Child. 2003;88(9):767-771. doi:10.1136/adc.88.9.767.
 
26.
McGhee SM, Ho LM, Lapsley HM, et al. Cost of tobacco-related diseases, including passive smoking, in Hong Kong. Tob Control. 2006;15(2):125-130. doi:10.1136/tc.2005.013292.
 
27.
Yang MC, Fann CY, Wen CP, Cheng T. Smoking attributable medical expenditures, years of potential life lost, and the cost of premature death in Taiwan. Tob Control. 2005;14(Suppl 1):i62-i70. doi:10.1136/tc.2004.007963.
 
28.
Sung HY, Chang LC, Wen YW, Tsai YW. The costs of smoking and secondhand smoke exposure in Taiwan: a prevalence-based annual cost approach. BMJ Open. 2014;4(7):e005199. doi:10.1136/bmjopen-2014-005199.
 
29.
John RM, Sung HY, Max W. Economic cost of tobacco use in India, 2004. Tob Control. 2009;18(2):138-143. doi:10.1136/tc.2008.027466.
 
30.
Warner KE, Hodgson TA, Carroll CE. Medical costs of smoking in the United States: estimates, their validity, and their implications. Tob Control. 1999;8(3):290-300. doi:10.1136/tc.8.3.290.
 
31.
Hodgson TA. Cigarette smoking and lifetime medical expenditures. Milbank Q. 1992;70(1):81-125. doi:10.2307/3350086.
 
32.
Rice DP, Hodgson TA, Sinsheimer P, Browner W, Kopstein AN. The economic costs of the health effects of smoking, 1984. Milbank Q. 1986;64(4):489-547. doi:10.2307/3349924.
 
33.
Yang G, Kong L, Zhao W, et al. Emergence of chronic non-communicable diseases in China. Lancet. 2008;372(9650):1697-1705. doi:10.1016/s0140-6736(08)61366-5.
 
eISSN:1617-9625